Thiamine-responsive megaloblastic anemia (TRMA) is an autosomal recessive syndrome characterized by early-onset anemia, diabetes, and hearing loss caused by mutations in the SLC19A2 gene. Here, SLC19A2 is linked to thiamine-responsive megaloblastic anemia syndrome.